Are you looking for TMS patient information?

Recent Posts

Introducing Horizon® Performance

Magstim, the pioneer of a revolutionary non-invasive treatment for depression, has announced that its latest TMS therapy product, the Horizon Performance, has achieved CE mark regulatory approval and 510(k) clearance from the FDA.

Magstim receive a contract from the Veteran Administration

Morrisville, NC, October 17, 2017 -- Magstim, a pioneer in the study and development of Transcranial Magnetic Stimulation (TMS), has received a contract from the Veterans Administration to help treat Major Depressive Disorder (MDD) in Veterans who have failed to achieve satisfactory improvement from prior antidepressant medication.

We use cookies to improve your experience and help us understand how you interact with us. Read our privacy policy.   Dismiss